New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/47/a0/3f/47a03f03-b595-12fe-9dc3-136566910bd5/mza_9141666422414174576.jpg/600x600bb.jpg

Medical Industry Feature

ReachMD

33 episodes

1 week ago

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

Science

Medicine

RSS

All content for Medical Industry Feature is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

Science

Medicine

New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma

Medical Industry Feature

1 month ago

New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma

Guest: Brian Gill, M.D.

Brian Gill, M.D., a neurosurgeon at NewYork-Presbyterian and Columbia, talks about a new clinical trial evaluating a device that can temporarily open the blood-brain barrier (BBB) to more effectively treat glioblastoma. Dr. Gill explains how this new sonication device uses focused ultrasound to temporarily disrupt the BBB in order to administer chemotherapy directly into the tumor bed. The trial is building on promising results from phase 1 and phase 2 trials, which demonstrated safety, efficacy, and the potential to enhance quality of life for patients with recurrent glioblastoma.